A new study from King’s College London shows that off-label prescriptions of a common antidepressant doesn’t help ...
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 ...
After 56 days of treatment, "worst breathlessness" over the past 24 hours -- the study's primary outcome -- was no different between patients allocated to receive a daily dose of mirtazapine or ...
A new study from King's College London shows that off-label prescriptions of a common antidepressant doesn't help ...
A new study from King's College London shows that off-label prescriptions of a common antidepressant doesn't help ...
This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://mc.manuscriptcentral ...